Skip to main content
Back To Top Top Back To Top
This website publishes administrative rules on their effective dates, as designated by the adopting state agencies, colleges, and universities.

Rule 3701-84-26 | Facilities/safety standards - bone marrow transplantation service.

 

(A) The hospital at which the blood and bone marrow transplant service is located will provide all of the following on site:

(1) A designated blood and bone marrow transplant unit with a sufficient number of beds to meet the needs of the transplant service;

(2) Active departments or sections in hematology/oncology, immunology and infectious diseases;

(3) Laboratories;

(4) Adequate intensive care facilities;

(5) Protective reverse isolation rooms with appropriate air handling characteristics (i.e., hepa-filtered positive pressure patient rooms);

(6) Radiologic services including, but not limited to, tomography, computed tomography (CT) scans and/or magnetic resonance imaging (MRI) scans;

(7) Radionuclide scans and ultrasonography;

(8) Immunopathology and hepatopathology;

(9) Histopathology;

(10) Microbiology laboratory;

(11) Blood banking services capable of routinely providing irradiated blood products appropriate for cytomegalovirus (CMV) seronegative patients;

(12) Clinical pharmacology services with a pharmacist familiar with antineoplastic agents;

(13) Modern radiotherapy capabilities including the ability to provide total body irradiation either on-site or through agreement or contract with another hospital;

(14) Operating room facilities; and

(15) Echocardiography or multigated blood-pool imaging (MUGA) scan capability.

(B) Each blood and bone marrow transplant service will have the following readily available:

(1) Tissue-typing laboratory;

(2) Apheresis capability with adequate blood cell component therapy and routine access to a blood irradiator; and

(3) Facilities to cryopreserve hematopoietic stem cells for transplantation and which additionally may be used to manipulate hematopoietic stem cells ex-vivo.

Last updated May 15, 2023 at 12:45 AM

Supplemental Information

Authorized By: 3702.11, 3702.13
Amplifies: 3702.11, 3702.12, 3702.13, 3702.14, 3702.141, 3702.15, 3702.16, 3702.18, 3702.19, 3702.20
Five Year Review Date: 5/5/2028
Prior Effective Dates: 3/1/1997, 3/24/2003, 6/1/2007, 6/21/2012, 8/1/2017